Published in Clin Lung Cancer on March 01, 2008
CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases. World J Surg Oncol (2012) 0.90
Thermal ablation of stage I non-small cell lung carcinoma. Semin Intervent Radiol (2014) 0.77
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med (2012) 3.52
Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (2010) 2.97
Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw (2013) 2.56
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2004) 2.20
Small cell lung cancer. J Natl Compr Canc Netw (2013) 2.04
Retrospective analysis of artifacts in four-dimensional CT images of 50 abdominal and thoracic radiotherapy patients. Int J Radiat Oncol Biol Phys (2008) 1.87
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res (2006) 1.71
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2009) 1.71
Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw (2014) 1.71
Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys (2007) 1.69
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol (2006) 1.53
Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol (2014) 1.51
Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol (2008) 1.50
RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat (2007) 1.48
ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancer. Am J Clin Oncol (2015) 1.39
Applying a structured innovation process to interventional radiology: a single-center experience. J Vasc Interv Radiol (2012) 1.37
Adjuvant chemotherapy of stage I non-small cell lung cancer in North America. J Thorac Oncol (2007) 1.32
Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors. Curr Treat Options Oncol (2007) 1.32
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst (2010) 1.31
Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol (2010) 1.30
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys (2009) 1.24
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res (2010) 1.22
Investigation of four-dimensional computed tomography-based pulmonary ventilation imaging in patients with emphysematous lung regions. Phys Med Biol (2011) 1.20
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2012) 1.18
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.15
Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys (2010) 1.13
Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors. J Thorac Oncol (2014) 1.10
Treatment of leptomeningeal spread of NSCLC: a continuing challenge. Curr Treat Options Oncol (2012) 1.09
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2007) 1.08
Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol (2012) 1.08
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 1.06
CyberKnife stereotactic ablative radiotherapy for lung tumors. Technol Cancer Res Treat (2010) 1.04
Intrapulmonary ectopic liver after orthotopic heart transplantation. Arch Pathol Lab Med (2010) 1.04
Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys (2010) 1.02
Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol (2009) 1.02
Malignant pleural mesothelioma. J Natl Compr Canc Netw (2012) 1.01
Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx. Head Neck (2011) 1.00
Complex retrieval of embedded IVC filters: alternative techniques and histologic tissue analysis. Cardiovasc Intervent Radiol (2011) 1.00
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2017) 0.99
Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol (2011) 0.99
Four-dimensional computed tomography pulmonary ventilation images vary with deformable image registration algorithms and metrics. Med Phys (2011) 0.98
Chemotherapy definitions and policies for thymic malignancies. J Thorac Oncol (2011) 0.98
Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest (2008) 0.95
AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancer. Curr Opin Mol Ther (2010) 0.95
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. J Natl Compr Canc Netw (2012) 0.95
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer (2012) 0.94
Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol (2010) 0.93
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol (2011) 0.93
Review of erlotinib in the treatment of advanced non-small cell lung cancer. Biologics (2007) 0.93
Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images. Int J Radiat Oncol Biol Phys (2012) 0.93
Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol (2010) 0.93
Sunitinib: a newly approved small-molecule inhibitor of angiogenesis. Drugs Today (Barc) (2006) 0.91
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. Int J Radiat Oncol Biol Phys (2012) 0.91
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease. Radiat Oncol (2012) 0.91
High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. Int J Radiat Oncol Biol Phys (2010) 0.90
Targeting VEGF in lung cancer. Expert Opin Ther Targets (2012) 0.90
PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06. Mol Imaging Biol (2013) 0.90
Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys (2012) 0.89
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent. Oncology (Williston Park) (2014) 0.89
Reproducibility of four-dimensional computed tomography-based lung ventilation imaging. Acad Radiol (2012) 0.89
Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. Med Phys (2011) 0.89
Anti-angiogenesis drugs in lung cancer. Respirology (2010) 0.88
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med (2007) 0.88
An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One (2013) 0.88
Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol (2008) 0.87
Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat (2007) 0.87
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.87
Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. J Thorac Oncol (2014) 0.86
Common iliac vein stenosis and risk of symptomatic pulmonary embolism: an inverse correlation. J Vasc Interv Radiol (2011) 0.86
An automated method for comparing motion artifacts in cine four-dimensional computed tomography images. J Appl Clin Med Phys (2012) 0.85
Optimization of doxorubicin loading for superabsorbent polymer microspheres: in vitro analysis. Cardiovasc Intervent Radiol (2011) 0.85
Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med (2012) 0.85
Optical detection of tumors in vivo by visible light tissue oximetry. Technol Cancer Res Treat (2005) 0.85
Second- and third-line treatments in non-small cell lung cancer. Curr Treat Options Oncol (2006) 0.84
Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study. J Thorac Dis (2012) 0.84
4D CT lung ventilation images are affected by the 4D CT sorting method. Med Phys (2013) 0.84
Photothermal ablation with the excimer laser sheath technique for embedded inferior vena cava filter removal: initial results from a prospective study. J Vasc Interv Radiol (2011) 0.84
C-arm computed tomography for hepatic interventions: a practical guide. J Vasc Interv Radiol (2010) 0.83
Synchronous rectovaginal, urinary bladder, and pulmonary endometriosis. JSLS (2005) 0.83
Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes. Discov Med (2010) 0.82
Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity. Radiother Oncol (2011) 0.82
Percutaneous cholecystostomy for acute cholecystitis: ten-year experience. J Vasc Interv Radiol (2011) 0.81
Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer. Curr Treat Options Oncol (2009) 0.81
Quantification of motion of different thoracic locations using four-dimensional computed tomography: implications for radiotherapy planning. Int J Radiat Oncol Biol Phys (2007) 0.81
Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study. J Nucl Med (2011) 0.80
Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver. J Vasc Interv Radiol (2012) 0.80
Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature" [Radiotherapy and Oncology 89 (2009) 245-253]. Radiother Oncol (2009) 0.80
Correlation of the diameter of the left common iliac vein with the risk of lower-extremity deep venous thrombosis. J Vasc Interv Radiol (2012) 0.80
Prophylactic topically applied ice to prevent cutaneous complications of nontarget chemoembolization and radioembolization. J Vasc Interv Radiol (2013) 0.79
The relationship between serial [(18) F]PBR06 PET imaging of microglial activation and motor function following stroke in mice. Mol Imaging Biol (2014) 0.79
A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol (2007) 0.79